Effects of thalidomide on vascular endothelial growth factors expression in endometrial stromal cells of endometriosis in vitro

In: Chinese Journal of New Drugs and Clinical Remedies · 2007 · pp. 641–645 · W2387107230
article OA: closed CC0
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-08

Thalidomide inhibited proliferation and reversed TNF-α-induced upregulation of VEGF expression and secretion in human endometrial stromal cells from endometriosis patients in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIM:To observe the effects of thalidomide (ThD) on cell proliferation and vascular endothe- lial growth factors (VEGF) expression in endometrial stromal cell of endometriosis in vitro.METHODS:Human endometrial tissue was obtained from patients with endometriosis.The stromal celXs were isolated and identified by immunohistochemical staining with vimentin antibody.The influence of tumor necrosis factor-alpha (TNF-α) and ThD on proliferation of endometrial stromal cells was observed.The effects of different concentration of ThD on VEGF expression in endometrial stromal cells were analyzed by real-time PCR,Western Blot and ELISA. RESULTS:TNF-αcould promote the proliferation of endometrial stromal cell and the secretion of VEGF,while ThD could inhibit the proliferation of endometrial stromal cell and reverse the up-regulation of VEGF expression by TNF-α.CONCLUSION:ThD could inhibit the proliferation of endometrial stromal cell and expression and secretion of VEGF in vitro,which suggested that ThD might have therapeutic effect on endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK